Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower

被引:39
作者
Nowell, W. Benjamin [1 ]
Gavigan, Kelly [1 ]
Kannowski, Carol L. [2 ]
Cai, Zhihong [3 ]
Hunter, Theresa [2 ]
Venkatachalam, Shilpa [1 ]
Birt, Julie [2 ]
Workman, Jennifer [2 ]
Curtis, Jeffrey R. [4 ]
机构
[1] Global Hth Living Fdn, Upper Nyack, NY 10960 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Eli Lilly Japan, Kobe, Hyogo, Japan
[4] Univ Alabama Birmingham, Birmingham, AL USA
关键词
Patient-reported outcomes; Real-world evidence; Rheumatoid arthritis; INADEQUATE RESPONSE; BARICITINIB; FATIGUE; FLARE; SET;
D O I
10.1186/s13075-021-02430-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Patient-reported outcomes (PROs) are increasingly used to track symptoms and to assess disease activity, quality of life, and treatment effectiveness. It is therefore important to understand which PROs patients with rheumatic and musculoskeletal disease consider most important to track for disease management. Methods Adult US patients within the ArthritisPower registry with ankylosing spondylitis, fibromyalgia syndrome, osteoarthritis, osteoporosis, psoriatic arthritis, rheumatoid arthritis, and systemic lupus erythematosus were invited to select between 3 and 10 PRO symptom measures they felt were important to digitally track for their condition via the ArthritisPower app. Over the next 3 months, participants (pts) were given the option to continue tracking their previously selected measures or to remove/add measures at 3 subsequent monthly time points (month [m] 1, m2, m3). At m3, pts prioritized up to 5 measures. Measures were rank-ordered, summed, and weighted based on pts rating to produce a summary score for each PRO measure. Results Among pts who completed initial selection of PRO assessments at baseline (N = 253), 140 pts confirmed or changed PRO selections across m1-3 within the specified monthly time window (28 days +/- 7). PROs ranked as most important for tracking were PROMIS Fatigue, Physical Function, Pain Intensity, Pain Interference, Duration of Morning Joint Stiffness, and Sleep Disturbance. Patient's preferences regarding the importance of these PROs were stable over time. Conclusion The symptoms that rheumatology patients prioritized for longitudinal tracking using a smartphone app were fatigue, physical function, pain, and morning joint stiffness.
引用
收藏
页数:10
相关论文
共 36 条
  • [1] Data linkages between patient-powered research networks and health plans: a foundation for collaborative research
    Agiro, Abiy
    Chen, Xiaoxue
    Eshete, Biruk
    Sutphen, Rebecca
    Clark, Elizabeth Bourquardez
    Burroughs, Cristina M.
    Nowell, W. Benjamin
    Curtis, Jeffrey R.
    Loud, Sara
    McBurney, Robert
    Merkel, Peter A.
    Sreih, Antoine G.
    Young, Kalen
    Haynes, Kevin
    [J]. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2019, 26 (07) : 594 - 602
  • [2] [Anonymous], 2009, GUIDANCE IND PARTICI
  • [3] 2019 American College of Rheumatology Recommended Patient-Reported Functional Status Assessment Measures in Rheumatoid Arthritis
    Barber, Claire E. H.
    Zell, JoAnn
    Yazdany, Jinoos
    Davis, Aileen M.
    Cappelli, Laura
    Ehrlich-Jones, Linda
    Everix, Donna
    Thorne, J. Carter
    Bohm, Victoria
    Suter, Lisa
    Limanni, Alex
    Michaud, Kaleb
    [J]. ARTHRITIS CARE & RESEARCH, 2019, 71 (12) : 1531 - 1539
  • [4] Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus
    Bartlett, Susan J.
    Hewlett, Sarah
    Bingham, Clifton O., III
    Woodworth, Thasia G.
    Alten, Rieke
    Pohl, Christoph
    Choy, Ernest H.
    Sanderson, Tessa
    Boonen, Annelies
    Bykerk, Vivian
    Leong, Amye L.
    Strand, Vibeke
    Furst, Daniel E.
    Christensen, Robin
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (11) : 1855 - 1860
  • [5] Methodological Standards and Patient-Centeredness in Comparative Effectiveness Research The PCORI Perspective
    Basch, Ethan
    Aronson, Naomi
    Berg, Alfred
    Flum, David
    Gabriel, Sherine
    Goodman, Steven N.
    Helfand, Mark
    Ioannidis, John P. A.
    Lauer, Michael
    Meltzer, David
    Mittman, Brian
    Newhouse, Robin
    Normand, Sharon-Lise
    Schneeweiss, Sebastian
    Slutsky, Jean
    Tinetti, Mary
    Yancy, Clyde
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (15): : 1636 - 1640
  • [6] BOERS M, 1994, J RHEUMATOL, V21, P86
  • [7] Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set
    Bykerk, Vivian P.
    Bingham, Clifton O.
    Choy, Ernest H.
    Lin, Daming
    Alten, Rieke
    Christensen, Robin
    Furst, Daniel E.
    Hewlett, Sarah
    Leong, Amye
    March, Lyn
    Woodworth, Thasia
    Boire, Gilles
    Haraoui, Boulos
    Hitchon, Carol
    Jamal, Shahin
    Keystone, Edward C.
    Pope, Janet
    Tin, Diane
    Thorne, J. Carter
    Bartlett, Susan J.
    [J]. RMD OPEN, 2016, 2 (01):
  • [8] Establishing a Core Domain Set to Measure Rheumatoid Arthritis Flares: Report of the OMERACT 11 RA Flare Workshop
    Bykerk, Vivian P.
    Lie, Elisabeth
    Bartlett, Susan J.
    Alten, Rieke
    Boonen, Annelies
    Christensen, Robin
    Furst, Daniel E.
    Hewlett, Sarah
    Leong, Amye L.
    Lyddiatt, Anne
    March, Lyn
    May, James E.
    Montie, Pam
    Orbai, Ana-Maria
    Pohl, Christoph
    Voshaar, Marieke Scholte
    Woodworth, Thasia
    Bingham, Clifton O., III
    Choy, Ernest H.
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (04) : 799 - 809
  • [9] Chen X., 2020, BMC HEALTH SERV RES, V20, P1
  • [10] Using technology to support clinical care and research in rheumatoid arthritis
    Dixon, William G.
    Michaud, Kaleb
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (03) : 276 - 281